Radiotherapeutic α particle effects on tumor growth and animal survival were assessed using immunocompetent C57BL/6J mice (♀ and ♂; 6–8 weeks old; Jackson Laboratory). Briefly, each animal received SC injections of 105 B16-F10 cells and 8 d later were randomly sorted into 3 groups of 10 animals (5♀ and 5♂ per group). Mice in each group received an IV injection of 11.1 kBq of [225Ac]αMSH-PEG-Cy5-C′ dot (Group I), 11.1 kBq of [225Ac]NH2-PEG-Cy5-C′ dot (Group II), or the 1% HSA injection vehicle (Group III) through retro-orbital sinus injection under anesthesia. The specific activity of the injected C′ dots is 227,484 ± 57,583 GBq/mol (n = 6) and 55 ± 12 pmol was injected. Tumor dimensions were measured using calipers and the volume calculated using the formula: volume = 1/2(length × width2). Mice were sacrificed when tumor was >2000 mm3 or if they exhibited lethargy. Survival was plotted using the Kaplan–Meier method and tumor samples from representative animals were harvested for histopathology.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.